ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kratom Bird Introduces ELYTHRA LABS: A New Era of Elevated Botanicals Through Strategic Collaboration

Kratom Bird partners with ELYTHRA LABS to launch lab-tested botanical wellness products in Europe, including MIT70 tablets, KANNA ULTRA EXTRACT, and the Kava & Kratom Shot. This collaboration blends science and tradition, delivering pure, potent plant-based solutions with fast, discreet EU and UK shipping.

-- Kratom Bird, a leading supplier of premium kratom in Europe, proudly announces its strategic collaboration with ELYTHRA LABS, an innovative botanical brand merging scientific precision with ancient plant wisdom to deliver ultra-pure, performance-driven wellness solutions.

Rooted in a shared commitment to purity, potency, and plant intelligence, this partnership is poised to reshape the botanical supplement landscape across Europe, offering scientifically formulated products that support mental clarity, natural relaxation, and emotional balance.

Pioneering Plant-Based Innovation

ELYTHRA LABS has earned recognition for its ability to translate traditional ethnobotanical practices into next-generation wellness products. Through controlled laboratory processes and stringent quality standards, the brand ensures clean-label formulations with no fillers, additives, or synthetic compounds.

“We are thrilled to partner with ELYTHRA LABS to bring their visionary formulas to our European customer base,” said the spokesperson and CEO of Kratom Bird. “This collaboration aligns with our mission to deliver lab-tested, high-performance botanicals without compromise.”

Spotlight on ELYTHRA LABS’ Flagship Formulas

The launch introduces three standout products, each crafted to meet diverse wellness needs:

  • MIT70
  • A sublingual tablet delivering 70 mg of pure mitragynine per dose for clean, steady energy and cognitive enhancement. Infused with a smooth tropical coconut flavor, it’s designed for efficiency without unnecessary additives.
  • KANNA ULTRA EXTRACT
  • A pharmaceutical-grade microtablet containing 5 mg of 99% kanna alkaloids, equivalent to 100 mg of standard 5% extract. This formula offers a gentle boost for focus, sociability, and emotional balance, complemented by a light Cotton Candy flavor.
  • Kratom Shot
  • A ready-to-drink 30 ml elixir that unites 50 mg of mitragynine with 375 mg of noble kavalactones. With a smooth Piña Colada taste, this shot delivers calm clarity and natural relief in a convenient, mess-free format.

Science Meets Tradition

Each product represents a fusion of traditional botanicals and modern science, designed for people seeking natural, effective, and rigorously tested wellness solutions. ELYTHRA LABS’ formulations are third-party lab verified, ensuring every batch is free from contaminants, pesticides, and synthetic materials.

With fast, discreet shipping through Kratom Bird across the UK and EU, customers can now experience cutting-edge botanical wellness with unmatched accessibility.

Contact Info:
Name: Omar
Email: Send Email
Organization: Kratom Bird
Website: http://www.kratombird.com

Release ID: 89166492

Should you detect any errors, issues, or discrepancies with the content contained within this press release, or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond and take necessary steps within the next 8 hours to resolve any identified issues or guide you through the removal process. We value the trust placed in us by our readers and remain dedicated to providing accurate and reliable information.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.